Trends,Sociodemographic and Hospital-Level Factors Associated With Palliative Care Utilization Among Multiple Myeloma Patients Using the National Inpatient Sample (2016-2018)

Abstract

Background:

Several factors are reported to be associated with palliative care utilization among patients with various cancers, but literature is lacking on multiple myeloma (MM) specific factors. MM patients have a high symptom burden and early involvement of palliative could increase their quality of life. We examined factors associated with palliative care utilization among MM patients and explored prevalence trends in palliative care utilization among patients with MM.

Methods:

Cross-sectional analyses were conducted using the National Inpatient Sample data collected between 2016 and 2018. Descriptive analyses were used to explore prevalence trends in palliative care utilization over time. Multivariable logistic regression models were used to examine sociodemographic and hospital-level factors associated with palliative care utilization in MM patients.

Results:

Overall prevalence of palliative care utilization in our population was 7.7% with a trend of increasing use of palliative care from 7.3% in 2016 to 8.2% in 2018. MM patients aged 70 years and above had 1.30 times higher odds (95% CI: 1.20-1.42) of receiving palliative care relative to those younger than 70 years. Compared to non-Hispanic whites, non-Hispanic blacks (Adjusted odds ratio (AOR): 0.86; 95% CI: 0.79-0.94) were less likely to utilize palliative care. Patients on Medicaid (AOR: 1.27; 95% CI: 1.08-1.49), private insurance (AOR: 1.27; 95% CI: 1.16-1.39) and other insurance types (AOR: 2.10; 95% CI: 1.79-2.47) had significantly higher odds of receiving palliative care when compared to those on Medicare. Other factors identified were hospital region, location, patient disposition, admission type, length of stay, and number of comorbidities.

Conclusion:

Our findings highlight the urgent need for education of hospital physicians on the need for early palliative care involvement in the care of hospitalized MM patients. Messaging interventions such as the delivery of pop-up messages in electronic medical records to serve as reminders for physicians can be explored as a potential way to increase palliative care consultations for patients who need them.

Keywords

palliative care multiple myeloma factors hospital-level factors sociodemographic factors cancer

Get full access to this article

View all access options for this article.

References

Albagoush

Azevedo

. Multiple myeloma. In: StatPearls [Internet]. StatPearls Publishing; Published July 2021. PMID: 30521185.

Rajkumar

. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol. 2018;93(8):981–1114.

Mian

Pond

Wildes

Sivapathasundaram

Sussman

Seow

. Symptom burden in transplant ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study. Haematologica. 2021;106(7):1991–1994.

Kamal

Wang

Shi

, et al. Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma. Support Care Cancer. 2021;29(1):467–475.

Kumar

Rajkumar

Dispenzieri

, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111(5):2516–2520.

Turesson

Bjorkholm

Blimark

Kristinsson

Velez

Landgren

. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival. Eur J Haematol. 2018;101(2):237–244.

Porta-Sales

Guerrero-Torrelles

Moreno-Alonso

, et al.

Is early palliative care feasible in patients with multiple myeloma?

J Pain Symptom Manage. 2017;54(5):692–700.

Stewart

Dimopoulos

Masszi

, et al. Health-related quality-of-life results from the open-label, randomized, phase III ASPIRE trial evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma. J Clin Oncol. 2016;34(32):3921–3930.

Radbruch

De Lima

Knaul

, et al. Redefining palliative care—a new consensus-based definition. J Pain Symptom Manage. 2020;60(4):754–764.

10.

Bowen

. The multidisciplinary team in palliative care: a case reflection. Indian J Palliat Care. 2014;20(2):142–145.

11.

Vissers

van den Brand

Jacobs

, et al. Palliative medicine update: a multidisciplinary approach. Pain Practice. 2013;13(7):576–588.

12.

Hui

Didwaniya

Vidal

, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120(10):1572–1578.

13.

Kirtane

Downey

Lee

Curtis

Engelberg

. Intensity of end-of-life care for patients with hematologic malignancies and the role of race/ethnicity. J Palliat Med. 2018;21(10):1466–1471.

14.

Hochman

Wolf

Samsa

Kamal

LeBlanc

. Comparing the palliative care needs of patients with hematologic and solid malignancies. J Pain Symptom Manage. 2018;55(1):82–88.e81.

15.

Verhoef

de Nijs

Ootjers

, et al. End-of-life trajectories of patients with hematological malignancies and patients with advanced solid tumors visiting the emergency department: the need for a proactive integrated care approach. Am J Hosp Palliat Care. 2020;37(9):692–700.

16.

Odejide

Cronin

Earle

LaCasce

Abel

. Hospice use among patients with lymphoma: impact of disease aggressiveness and curability. J Natl Cancer Inst. 2016;108(1):djv280.

17.

Abbasi

Roller

Abdallah

, et al. Hospitalization at the end of life in patients with multiple myeloma. BMC Cancer. 2021;21(1):339.

18.

Schoenherr

Bischoff

Marks

O’Riordan

Pantilat

. Trends in hospital-based specialty palliative care in the United States from 2013 to 2017. JAMA Network Open. 2019;2(12):e1917043–e1917043.

19.

Hawley

. Barriers to access to palliative care. Palliat Care. 2017;10:1178224216688887.

20.

Ramsenthaler

Osborne

Gao

, et al. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer. 2016;16:427–427.

21.

Meier

. Palliative care in hospitals. J Hosp Med. 2006;1(1):21–28.

22.

Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality. Accessed September 2021. https://www.ahrq.gov/data/hcup/index.html

23.

Houchens

Ross

Elixhauser

. Final Report on Calculating National Inpatient Sample (NIS) Variances for Data Years 2012 and Later. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality; 2015.

24.

HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2016-2018. Agency for Healthcare Research and Quality, Rockville, MD. Accessed September 06, 2021. www.hcup-us.ahrq.gov/nisoverview.jsp

25.

Liu

Han

Shah

, et al. Significant nationwide variability in the costs and hospital mortality rates of autologous stem cell transplantation for multiple myeloma: an analysis of the nationwide inpatient sample database. Biol Blood Marrow Transplant. 2019;25(1):41–46.

26.

Bedi

Rai

Kaner

, et al. Patterns of inpatient care and outcomes for multiple myeloma in 2014: a national inpatient sample analysis. Blood. 2018;132:4748.

27.

Jackson

Musoke

. Racial disparities in hospitalization outcomes among adult multiple myeloma patients using the national inpatient sample (2016-2018) [published online August 7, 2021]. Hematol Oncol. 2021. PMID: 34363709 doi: 10.1002/hon.2907

28.

Vakiti

Patel

Jonnalagadda

, et al. Trends of hospitalization for multiple myeloma patients: insights from the national inpatient sample database. J Clin Oncol. 2018;36(15_suppl):e20015–e20015.

29.

StataCorp. Stata Statistical Software: Release 16. StataCorp LLC. 2019.

30.

Bhulani

Gupta

Gao

, et al. Palliative care and end-of-life health care utilization in elderly patients with pancreatic cancer. J Gastrointest Oncol. 2018;9(3):495–502.

31.

D’Angelo

Di Nitto

Giannarelli

, et al. Inequity in palliative care service full utilisation among patients with advanced cancer: a retrospective Cohort study. Acta Oncologica. 2020;59(6):620–627.

32.

Heller

Jean

Chiu

, et al. Regional differences in palliative care utilization among geriatric colorectal cancer patients needing emergent surgery. J Gastrointest Surg. 2019;23(1):153–162.

33.

Janah

Gauthier

Morin

, et al. Access to palliative care for cancer patients between diagnosis and death: a national cohort study. Clin Epidemiol. 2019;11:443.

34.

Sullivan

Chan

Lapidus

, et al. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans Health Administration. JAMA Oncol. 2019;5(12):1702–1709.

35.

Bauman

Temel

. The integration of early palliative care with oncology care: the time has come for a new tradition. J Natl Compr Canc Netw. 2014;12(12):1763–1771.

36.

Ferrell

Temel

Temin

, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(1):96–112.

37.

Smith

Earle

McCarthy

. Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc. 2009;57(1):153–158.

38.

Fairfield

Murray

Wierman

, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol. 2012;125(1):14–18.

39.

Lackan

Ostir

Freeman

Mahnken

Goodwin

. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Medical Care. 2004:116–122.

40.

Patel

Sterling

Srivastava

, et al. Factors associated with palliative care utilization in advanced and metastatic renal cell carcinoma. J Clin Oncol. 2021;39(suppl 6):297.

41.

Sharma

Cameron

Chmiel

, et al. Racial/ethnic differences in inpatient palliative care consultation for patients with advanced cancer. J Clin Oncol. 2015;33(32):3802.

42.

Colibaseanu

Osagiede

Spaulding

, et al. The determinants of palliative care use in patients with colorectal cancer: a national study. Am J Hosp Palliat Care. 2018;35(10):1295–1303.

43.

Di Luca

Feldman

Jimsheleishvili

, et al. Trends of inpatient palliative care use among hospitalized patients with Parkinson’s disease. Parkinsonism Relat Disord. 2020;77:13–17.

44.

Wen

Jiang

Koncicki

, et al. Trends and racial disparities of palliative care use among hospitalized patients with ESKD on dialysis. J Am Soc Nephrol. 2019;30(9):1687–1696.

45.

Milki

Mann

Gardner

Kapp

English

Chan

. Trends in the utilization of palliative care in patients with gynecologic cancer who subsequently died during hospitalization. Am J Hosp Palliat Care. 2021;38(2):138–146.

46.

Ward

Halpern

Schrag

, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58(1):9–31.

47.

Dumanovsky

Augustin

Rogers

Lettang

Meier

Morrison

. The growth of palliative care in U.S. hospitals: a status report. J Palliat Med. 2016;19(1):8–15.

48.

Meier

. Increased access to palliative care and hospice services: opportunities to improve value in health care. Milbank Q. 2011;89(3):343–380.

49.

Liu

Dawod

Wonnaparhown

, et al. Effects of hospital palliative care on health, length of stay, and in-hospital mortality across intensive and non-intensive-care units: a systematic review and metaanalysis. Palliat Support Care. 2017;15(6):741–752.

50.

Kolovos

Nador

Kishore

, et al. Unplanned admissions for patients with myeloma in the UK: low frequency but high costs. J Bone Oncology. 2019;17:100243–100243.

51.

Centers for Disease Control and Prevention: National Center for Health Statistics. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Updated July 30, 2021. Accessed September 29, 2021. https://www.cdc.gov/nchs/icd/icd10cm.htm

52.

Hua

Clancy

Morrison

Wunsch

. Validation of the V66.7 code for palliative care consultation in a single academic medical center. J Palliat Med. 2017;20(4):372–377.